Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed Nov 10, 2022 · 10-Q · 41 days after period end · 0001826466-22-000142
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | $6.34K | -$2.70K | -$160.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 10, 2022 · 41 d after period end
